<DOC>
	<DOCNO>NCT00890903</DOCNO>
	<brief_summary>The purpose non-interventional study collect data efficacy toxicity use Navelbine ORAL daily routine Germany ( especially availability 80mg capsule ) . The study focus concomitant antiemetic therapy patient compliance .</brief_summary>
	<brief_title>Non-Interventional Study With Vinorelbine ORAL Advanced Non-Small Cell Lung Carcinoma ( NSCLC ) Metastatic Breast Cancer ( MBC )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<criteria>At least 18 year old Male female patient Advanced NSCLC ( Stage III IV ) Antracyclineresistant MBC Therapy Navelbine capsule palliative treatment line Signed patient inform consent Pregnancy nurse All exclusion criterion list SPC ( summary product characteristic ) lack sign Patient inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>non small cell lung carcinoma</keyword>
	<keyword>metastatic breast cancer</keyword>
	<keyword>MBC</keyword>
	<keyword>advanced breast cancer</keyword>
	<keyword>Navelbine</keyword>
	<keyword>Navelbine-ORAL</keyword>
	<keyword>Vinorelbine</keyword>
	<keyword>Vinorelbine-ORAL</keyword>
	<keyword>daily routine</keyword>
	<keyword>concomitant antiemetic therapy</keyword>
	<keyword>patient compliance</keyword>
	<keyword>germany</keyword>
	<keyword>non-interventional study</keyword>
	<keyword>oral anti cancer therapy</keyword>
	<keyword>quality life</keyword>
</DOC>